Sin conexión a internet: se muestra la versión guardada de la página.

Cellectis SA

USUSD
← Al screener

Cellectis SA (PA:ALCLS) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 3. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la empresa

Sitio web
cellectis.com
Relaciones con los inversores
cellectis.com/en/investors/governance/
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Sede central
France, France
Consejero delegado
Andre Choulika
Empleados
224
Fundada
1999
Acciones en circulación
72.72 M
Capital flotante
48.58 M
Capitalización bursátil
148.06 M USD
Insiders
0%
Inversores institucionales
15.36%
Industria (SIC)
Biological Products, (No Diagnostic Substances)
Forma jurídica
QVPB
ISIN
FR0010425595
LEI
5493000KKX5VQ37Q2W83
FCF
−41.8 M USD
Deuda
0
Resultados y FCF — para los 12 meses hasta 31.12.2025 (el último informe de la empresa).
Descripción

Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing BALLI-01, to evaluate the safety, expansion, persistence, and clinical activities of lasme-cel in patients with r/r ALL; NatHaLi-01, designed to evaluate the safety, expansion, persistence, and clinical activity of eti-cel in patients with relapsed or refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL). It also develops ALPHA3, targets Large B-Cell Lymphoma (LBCL); TRAVERSE, for the treatment of patients with advanced or metastatic clear cell renal cell carcinoma (RCC). In addition, the company Melanoma, for treatment of unresectable or metastatic melanoma. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.

Bolsas y tickers

BolsaTickerMonedaPrecioTipo
US USA StocksCMVLF OTCUSD3.47 +12.66%acciones ordinarias
LSE London Stock Exchange0WA2 IOBEUR2.65 +0.00%acciones ordinarias
PA Euronext ParisALCLS principalEUR1.128 +0.18%acciones ordinarias

Precio en 3 meses

día alcista día bajistaPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Noticias de esta semana

Aún no hay noticias del sitio web de la empresa.

anuncio

Principales accionistas

TitularParticipaciónAccionesFecha del informe
B Group, Inc.4.55%3.28 M2026-06-30
Long Focus Capital Manag…3.8%2.74 M2026-06-30
UBS AM, a distinct busin…3.67%2.64 M2026-06-30
iShares Trust-iShares Bi…0.33%235 6962026-08-31
Nomura Asset Management…0.31%226 8752026-06-30
Delaware Group Equity Fu…0.31%226 8752026-06-30
Blackrock Inc.0.31%225 4442026-06-30
Morgan Stanley0.12%85 4552026-06-30
LPL Financial LLC0.12%84 4152026-06-30
Susquehanna Internationa…0.07%50 4532026-06-30
BNP Paribas Financial Ma…0.06%40 1002026-06-30
UBS Group AG0.05%33 9262026-06-30
Fidelity Concord Street…0%1 9492026-07-31